Charles Schwab Investment Management »

Cyteir Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Cyteir Therapeutics shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Cyteir Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cyteir Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cyteir Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $49k 16k 3.04
2023-09-30 $45k 16k 2.84
2023-06-30 $42k 16k 2.60
2022-03-31 $158k 42k 3.78
2021-12-31 $259k 23k 11.40
2021-09-30 $361k 21k 17.55

More positions owned by Charles Schwab Investment Management

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Home Depot (HD)
Alphabet Cap Stk Cl C (GOOG)
Chevron Corporation (CVX)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Abbvie (ABBV)
Verizon Communications (VZ)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Coca-Cola Company (KO)

View all positions for Charles Schwab Investment Management

Top funds holding Cyteir Therapeutics

BML Capital Management
Acadian Asset Management
Boston Family Office
Lindbrook Capital

View all funds holding Cyteir Therapeutics